Searched for
EXPEDIENT HEALTHCARE
Govt bans select cough syrups for kids below 4 yearsThe government has prohibited cough syrups containing chlorpheniramine maleate and phenylephrine hydrochloride for children under four due ...- '70,000 gig workers registered on eShram'Over 70,000 gig workers have registered with the eShram portal, benefiting from social security schemes, after the onboarding of ten major ...
- Home Ministry asks states to take precautions against COVID-19 in jails, other detention facilitiesThe virus which causes the disease is highly infectious and even pre-symptomatic people can infect others, and any person who is in close c...
- Centre sends four interministerial teams to monitor COVID-19 situation in Gujarat, Telangana, TNThese teams, headed by Additional Secretary-level officers, will visit Ahmedabad, Surat, Hyderabad and Chennai, Home Ministry Joint Secreta...
- COVID-19: Orders for over 10 crore anti-malarial hydroxychloroquine tablets placed by CentreThe Indian Council of Medical Research (ICMR) has recommended the anti-malarial drug for those involved in the care of suspected or confirm...
- RFL scam: Court rejects bail plea of ex-Fortis Healthcare promoter Shivinder SinghSingh's brother Malvinder (46), also a former Fortis Healthcare promoter, Sunil Godhwani (58), Kavi Arora (48) and Anil Saxena were arreste...
- Unfortunate that some states opted out of Ayushman Bharat: Nirmala SitharamanIn a Facebook post dated January 23, Sitharaman said, "it is very unfortunate that some states have chosen to opt out of the scheme for rea...
- NaMo app controversy: US-based analytics firm says it doesn't 'sell, rent' dataCleverTap employees don't have access to any of the data stored with it by a publisher," Anand Jain, co-founder of California-based firm, t...
- SC for relook into 349 FDC medicines by drug advisory boardThe FDC were banned by the Centre on the grounds that they involved "risk" to humans and safer alternatives were available.
- SC refers 349 FDC medicines to Drug Advisory Board for relookA bench said that the 349 FDCs were banned pursuant to the Kokate Committee report, by notifications of the central government under Sectio...
- Core Diagnostics scores Rs 84 crore in fresh funding in round led by Fidelity investment armsProceeds from the Series B round of funding, which also saw participation from existing investor Artiman Ventures, will be used by the Gurg...
- Cricketer Yuvraj Singh-backed Healthians raises Rs 20 crThe Gurgaon-based venture, which aggregates local pathology laboratories on its platform, competes with a number of diagnostics chains, inc...
- Punish countries that undermine international trade pacts: UN PanelIn a report on access to drugs, the high-level panel has strongly urged the use of flexibility under Trade-Related Aspects of Intellectual ...
- HC reserves verdict on pleas against ban on 344 FDCsThe court had on March 14 stayed the Centre's ban on 344 FDC drugs and this interim order was passed in each and every case filed before it...
- Government banned fixed drug combinations without considering clinical data: Pharma companies to HCThe companies termed as "absurd" the government's claim that it took the decision to ban the FDCs on the ground that safer alternatives wer...
- HC to resume hearing on pharma cos' pleas against Centre's orderThe companies have contended that the decision was taken by the government without issuing them a show cause notice or granting them a hear...
- Centre ban on FDCs: Procter and Gamble, Glenmark, Reckitt Benckiser too get Delhi High Court reliefAs a result of the court's order, the ban on sale of P&G's Vicks Action 500 extra, Reckitt's D'Cold and Piramal's Saridon have been lifted ...
- Telecom, power, oil sectors most vulnerable to policy risks: StudyThe study further highlighted that industry's woes would be compounded in case the country's electorate votes a fractured mandate.
- Budget 2012: Long-term focus, good for the core sector, says Mukesh AmbaniFM has done a good job in paving a steady course by continuing to focus on reinforcing infrastructure and strengthening access to rural cre...
- Biocon to market Abraxis' breast cancer drug in IndiaBiocon Ltd on Thursday announced it has entered into a licensing agreement with US-based Abraxis BioScience Inc for selling 'Abraxane' in I...
Load More
